Iroko Pharmaceuticals, LLC
13
0
0
12
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 5/100
7.7%
1 terminated/withdrawn out of 13 trials
92.3%
+5.8% vs industry average
54%
7 trials in Phase 3/4
92%
11 of 12 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Study of Indomethacin Capsules to Treat Pain Following Surgery in Children Ages 6 to <17 Years of Age
Role: lead
Study of Diclofenac Capsules to Treat Pain Following Surgery in Children Ages 6 to <17 Years of Age
Role: lead
Meloxicam SoluMatrix® Capsules vs Meloxicam Tablets to Treat Osteoarthritis Pain
Role: lead
Study of Meloxicam Capsules in Subjects With Osteoarthritis of the Knee or Hip
Role: lead
Study of Meloxicam Capsules to Treat Osteoarthritis Pain
Role: lead
Study of Diclofenac Capsules to Treat Osteoarthritis Pain
Role: lead
Open-Label Study of Diclofenac Capsules to Treat Osteoarthritis Pain
Role: lead
Study of Indomethacin Capsules to Treat Pain Following Bunionectomy
Role: lead
Study of Indomethacin Capsules to Treat Pain Following Bunionectomy
Role: lead
Study of Diclofenac Capsules to Treat Pain Following Bunionectomy
Role: lead
Study of Diclofenac Capsules to Treat Dental Pain
Role: lead
Study of Naproxen Capsules to Treat Dental Pain
Role: lead
Phase 2 Study of Indomethacin Capsules to Treat Dental Pain
Role: lead
All 13 trials loaded